9.66

2.44% 0.23

After Hours: 9.66

Haleon Plc Adr (HLN)

Overview News Price History Option Chain Discussions Forecast Dividend History

Haleon Plc Adr stock is traded at $9.66, with a volume of 16.96M. It is up +2.44% in the last 24 hours and down -6.67% over the past month. Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Previous Close:

$9.43

Open:

$9.7

24h Volume:

16.96M

Relative Volume:

1.12

Market Cap:

$43.40B

Revenue:

$14.35B

Net Income/Loss:

$1.85B

P/E Ratio:

24.01

EPS:

0.4023

Net Cash Flow:

1W Performance:

-2.23%

1M Performance:

-6.67%

6M Performance:

+2.01%

1Y Performance:

+3.54%

1-Day Range:

$9.62

$9.76

1-Week Range:

$9.405

$9.85

52-Week Range:

$8.86

$11.42

Haleon Plc Adr Stock (HLN) Company Profile

Name

Haleon Plc Adr

Sector

Healthcare (1164)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

Address

Employee

24,622

Twitter

Next Earnings Date

2024-08-02

Latest SEC Filings

HLN's Discussions on Twitter

Compare HLN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HLN Haleon Plc Adr	9.66	42.36B	14.35B	1.85B	0	0.4023
ZTS Zoetis Inc	147.38	64.91B	9.29B	2.52B	2.28B	5.57
TAK Takeda Pharmaceutical Co Adr	14.16	43.33B	30.08B	710.16M	4.45B	0.2182
TEVA Teva Pharmaceutical Industries Ltd Adr	15.38	17.72B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	294.28	12.42B	2.99B	1.21B	1.13B	25.06

Haleon Plc Adr Stock (HLN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-27-25	Upgrade	BNP Paribas Exane	Neutral → Outperform
May-09-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Mar-05-25	Downgrade	HSBC Securities	Buy → Hold
Jan-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-08-25	Downgrade	Bernstein	Outperform → Mkt Perform
Aug-06-24	Initiated	Berenberg	Buy
Aug-06-24	Downgrade	Goldman	Buy → Neutral
Jun-05-24	Initiated	Berenberg	Buy
Apr-17-24	Initiated	HSBC Securities	Buy
Dec-11-23	Resumed	Jefferies	Buy
Nov-01-23	Initiated	Morgan Stanley	Overweight
May-24-23	Initiated	Stifel	Hold
Apr-06-23	Upgrade	Argus	Hold → Buy
Apr-04-23	Initiated	Bernstein	Outperform
Dec-07-22	Upgrade	Barclays	Equal Weight → Overweight
Sep-28-22	Initiated	Argus	Hold

View All

Haleon Plc Adr Stock (HLN) Latest News

10:19 AM

Haleon reports updated share capital and voting rights - Investing.com

10:19 AM

01:38 AM

Haleon PLC Reports Strong Profit Growth and Upgraded Guidance - TipRanks

01:38 AM

Jul 31, 2025

Haleon plc's 2025 Interim Dividend: A Strategic Dividend Play in a Low-Yield World - AInvest

Jul 31, 2025

Jul 30, 2025

Comparing Sharps Technology (NASDAQ:STSS) & Haleon (NYSE:HLN) - Defense World

Jul 30, 2025

Haleon PLC Sponsored ADR (NYSE:HLN) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Jul 30, 2025

Jul 29, 2025

HLN’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Jul 29, 2025

Jul 22, 2025

Haleon PLC Reports Change in Major Holdings by Wellington Management - MSN

Jul 22, 2025

Jul 21, 2025